This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (179)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Psychiatry, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Decreased Glutamic Acid Decarboxylase₆₇ Messenger RNA Expression in a Subset of Prefrontal Cortical -Aminobutyric Acid Neurons in Subjects With Schizophrenia

David W. Volk, MS; Mark C. Austin, PhD; Joseph N. Pierri, MS, MD; Allan R. Sampson, PhD; David A. Lewis, MD

Arch Gen Psychiatry. 2000;57:237-245.

Background  Markers of -aminobutyric acid (GABA) neurotransmission seem to be altered in the prefrontal cortex (PFC) of subjects with schizophrenia. We sought to determine whether the expression of the messenger RNA (mRNA) for the synthesizing enzyme of GABA, glutamic acid decarboxylase₆₇ (GAD₆₇), is decreased in the PFC of subjects with schizophrenia, whether this change is present in all or only some GABA neurons, and whether long-term treatment with haloperidol decanoate contributes to altered GAD₆₇ mRNA expression.

Methods  Tissue sections from 10 pairs of subjects with schizophrenia and control subjects and 4 pairs of haloperidol-treated and control monkeys were processed for in situ hybridization histochemical analysis with sulfur-35–labeled oligonucleotide probes for GAD₆₇ mRNA and exposed to nuclear emulsion. Within each layer of PFC area 9, neurons expressing a detectable level of GAD₆₇ mRNA were quantified for cell density and the relative level of mRNA expression per cell (grain density per neuron).

Results  In subjects with schizophrenia, the density of labeled neurons was significantly (P<.05) decreased by 25% to 35% in cortical layers 3 to 5. In contrast, the mean grain density per labeled neuron did not differ across subject groups. Similar analyses in monkeys revealed no effect of long-term haloperidol treatment on either the density of the labeled neurons or the grain density per labeled neuron.

Conclusions  These findings indicate that in subjects with schizophrenia, GAD₆₇ mRNA expression is relatively unaltered in most PFC GABA neurons but is reduced below a detectable level in a subset of GABA neurons. Altered GABA neurotransmission in this subset may contribute to PFC dysfunction in subjects with schizophrenia.

From the Departments of Neuroscience (Mr Volk and Dr Lewis), Psychiatry (Drs Austin, Pierri, and Lewis), and Statistics (Dr Sampson), University of Pittsburgh, Pittsburgh, Pa.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review of Pathological Hallmarks of Schizophrenia: Comparison of Genetic Models With Patients and Nongenetic Models
Jaaro-Peled et al.
Schizophr Bull 2009;0:sbp133v1-sbp133.
ABSTRACT | FULL TEXT  

Diminished Orientation-Specific Surround Suppression of Visual Processing in Schizophrenia
Yoon et al.
Schizophr Bull 2009;35:1078-1084.
ABSTRACT | FULL TEXT  

A Loss of Parvalbumin-Containing Interneurons Is Associated with Diminished Oscillatory Activity in an Animal Model of Schizophrenia
Lodge et al.
J. Neurosci. 2009;29:2344-2354.
ABSTRACT | FULL TEXT  

Dopamine D4 Receptors Regulate AMPA Receptor Trafficking and Glutamatergic Transmission in GABAergic Interneurons of Prefrontal Cortex
Yuen and Yan
J. Neurosci. 2009;29:550-562.
ABSTRACT | FULL TEXT  

Altered Expression of Genes Involved in GABAergic Transmission and Neuromodulation of Granule Cell Activity in the Cerebellum of Schizophrenia Patients
Bullock et al.
Am. J. Psychiatry 2008;165:1594-1603.
ABSTRACT | FULL TEXT  

Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia
Lewis et al.
Am. J. Psychiatry 2008;165:1585-1593.
ABSTRACT | FULL TEXT  

GABA Neurons and the Mechanisms of Network Oscillations: Implications for Understanding Cortical Dysfunction in Schizophrenia
Gonzalez-Burgos and Lewis
Schizophr Bull 2008;34:944-961.
ABSTRACT | FULL TEXT  

Prolonged Exposure to NMDAR Antagonist Suppresses Inhibitory Synaptic Transmission in Prefrontal Cortex
Zhang et al.
J. Neurophysiol. 2008;100:959-965.
ABSTRACT | FULL TEXT  

Association of Dorsolateral Prefrontal Cortex Dysfunction With Disrupted Coordinated Brain Activity in Schizophrenia: Relationship With Impaired Cognition, Behavioral Disorganization, and Global Function
Yoon et al.
Am. J. Psychiatry 2008;165:1006-1014.
ABSTRACT | FULL TEXT  

Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
Eggan et al.
Arch Gen Psychiatry 2008;65:772-784.
ABSTRACT | FULL TEXT  

Alterations in Somatostatin mRNA Expression in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia or Schizoaffective Disorder
Morris et al.
Cereb Cortex 2008;18:1575-1587.
ABSTRACT | FULL TEXT  

Conserved Regional Patterns of GABA-Related Transcript Expression in the Neocortex of Subjects With Schizophrenia
Hashimoto et al.
Am. J. Psychiatry 2008;165:479-489.
ABSTRACT | FULL TEXT  

Amygdala Gene Expression Correlates of Social Behavior in Monkeys Experiencing Maternal Separation
Sabatini et al.
J. Neurosci. 2007;27:3295-3304.
ABSTRACT | FULL TEXT  

Cognitive Dysfunction in Schizophrenia: Convergence of {gamma}-Aminobutyric Acid and Glutamate Alterations.
Lewis and Moghaddam
Arch Neurol 2006;63:1372-1376.
ABSTRACT | FULL TEXT  

Reversal of brain injury-induced prefrontal glutamic acid decarboxylase expression and working memory deficits by D1 receptor antagonism.
Kobori and Dash
J. Neurosci. 2006;26:4236-4246.
ABSTRACT | FULL TEXT  

BDNF Val66Met Polymorphism and GAD67 mRNA Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Hashimoto and Lewis
Am. J. Psychiatry 2006;163:534-537.
ABSTRACT | FULL TEXT  

Regulation of Cortical Interneurons by Neurotrophins: From Development to Cognitive Disorders
Woo and Lu
Neuroscientist 2006;12:43-56.
ABSTRACT  

From The Cover: The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases
Simonini et al.
Proc. Natl. Acad. Sci. USA 2006;103:1587-1592.
ABSTRACT | FULL TEXT  

Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Akbarian et al.
Arch Gen Psychiatry 2005;62:829-840.
ABSTRACT | FULL TEXT  

Neural Cell Adhesion Molecule-Secreting Transgenic Mice Display Abnormalities in GABAergic Interneurons and Alterations in Behavior
Pillai-Nair et al.
J. Neurosci. 2005;25:4659-4671.
ABSTRACT | FULL TEXT  

Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex
Petrie et al.
J. Neurosci. 2005;25:1629-1636.
ABSTRACT | FULL TEXT  

In psychosis, cortical interneurons overexpress DNA-methyltransferase 1
Veldic et al.
Proc. Natl. Acad. Sci. USA 2005;102:2152-2157.
ABSTRACT | FULL TEXT  

Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia
Hashimoto et al.
J. Neurosci. 2005;25:372-383.
ABSTRACT | FULL TEXT  

Mechanisms Underlying Differential D1 versus D2 Dopamine Receptor Regulation of Inhibition in Prefrontal Cortex
Trantham-Davidson et al.
J. Neurosci. 2004;24:10652-10659.
ABSTRACT | FULL TEXT  

Density of Glutamic Acid Decarboxylase 67 Messenger RNA-Containing Neurons That Express the N-Methyl-D-Aspartate Receptor Subunit NR2A in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder
Woo et al.
Arch Gen Psychiatry 2004;61:649-657.
ABSTRACT | FULL TEXT  

Decreased Thalamic Expression of the Homeobox Gene DLX1 in Psychosis
Kromkamp et al.
Arch Gen Psychiatry 2003;60:869-874.
ABSTRACT | FULL TEXT  

The Extended Amygdala and the Dopamine System: Another Piece of the Dopamine Puzzle
Fudge and Emiliano
J. Neuropsychiatry Clin. Neurosi. 2003;15:306-316.
ABSTRACT | FULL TEXT  

Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia
Hashimoto et al.
J. Neurosci. 2003;23:6315-6326.
ABSTRACT | FULL TEXT  

Epigenetic Downregulation of GABAergic Function in Schizophrenia: Potential for Pharmacological Intervention?
Costa et al.
Mol. Interv. 2003;3:220-229.
ABSTRACT | FULL TEXT  

White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis et al.
Arch Gen Psychiatry 2003;60:443-456.
ABSTRACT | FULL TEXT  

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability
Tremolizzo et al.
Proc. Natl. Acad. Sci. USA 2002;99:17095-17100.
ABSTRACT | FULL TEXT  

Delayed Mesolimbic System Alteration in a Developmental Animal Model of Schizophrenia
Goto and O'Donnell
J. Neurosci. 2002;22:9070-9077.
ABSTRACT | FULL TEXT  

Reciprocal Alterations in Pre- and Postsynaptic Inhibitory Markers at Chandelier Cell Inputs to Pyramidal Neurons in Schizophrenia
Volk et al.
Cereb Cortex 2002;12:1063-1070.
ABSTRACT | FULL TEXT  

Genetics and Etiopathophysiology of Schizophrenia
Sobell et al.
Mayo Clin Proc. 2002;77:1068-1082.
ABSTRACT  

Implications for Altered Glutamate and GABA Metabolism in the Dorsolateral Prefrontal Cortex of Aged Schizophrenic Patients
Gluck et al.
Am. J. Psychiatry 2002;159:1165-1173.
ABSTRACT | FULL TEXT  

Differential Hippocampal Expression of Glutamic Acid Decarboxylase 65 and 67 Messenger RNA in Bipolar Disorder and Schizophrenia
Heckers et al.
Arch Gen Psychiatry 2002;59:521-529.
ABSTRACT | FULL TEXT  

Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia
Middleton et al.
J. Neurosci. 2002;22:2718-2729.
ABSTRACT | FULL TEXT  

Lamina-Specific Deficits in Parvalbumin-Immunoreactive Varicosities in the Prefrontal Cortex of Subjects With Schizophrenia: Evidence for Fewer Projections From the Thalamus
Lewis et al.
Am. J. Psychiatry 2001;158:1411-1422.
ABSTRACT | FULL TEXT  

Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse
Liu et al.
Proc. Natl. Acad. Sci. USA 2001;98:3477-3482.
ABSTRACT | FULL TEXT  

GABA Transporter-1 mRNA in the Prefrontal Cortex in Schizophrenia: Decreased Expression in a Subset of Neurons
Volk et al.
Am. J. Psychiatry 2001;158:256-265.
ABSTRACT | FULL TEXT  

Schizophrenia: What's Under the Microscope?
Taber et al.
J. Neuropsychiatry Clin. Neurosi. 2001;13:1-4.
FULL TEXT  

Decrease in Reelin and Glutamic Acid Decarboxylase67 (GAD67) Expression in Schizophrenia and Bipolar Disorder: A Postmortem Brain Study
Guidotti et al.
Arch Gen Psychiatry 2000;57:1061-1069.
ABSTRACT | FULL TEXT  

Is There a Neuropathology of Schizophrenia? Recent Findings Converge on Altered Thalamic-Prefrontal Cortical Connectivity
Lewis
Neuroscientist 2000;6:208-218.
ABSTRACT  

Subnucleus-specific loss of neurons in medial thalamus of schizophrenics
Popken et al.
Proc. Natl. Acad. Sci. USA 2000;97:9276-9280.
ABSTRACT | FULL TEXT